Found 4 matching trials
Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes. NA Diabetes mellitus (DM) is a chronic inflammatory disease characterized by i...
Show More Location
National Taiwan University Hospital.
Learn More & Join Trial
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD NA Participants with chronic kidney disease (CKD) are at a higher risk of deve...
Show More Learn More & Join Trial
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease NA In patients with chronic kidney disease (CKD), uremic toxins accumulate whe...
Show More Learn More & Join Trial
Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function NA Taiwan has more chronic kidney disease (CKD) per capita than anywhere in th...
Show More Learn More & Join Trial